MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 199 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.76 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,037,614 | -80.2% | 7,105 | -68.7% | 0.00% | -100.0% |
| Q2 2023 | $5,247,627 | -2.0% | 22,717 | +2.8% | 0.00% | 0.0% |
| Q1 2023 | $5,352,492 | -44.1% | 22,094 | -33.0% | 0.00% | -66.7% |
| Q4 2022 | $9,573,606 | +2367.4% | 32,984 | +452.5% | 0.00% | – |
| Q3 2022 | $388,000 | +1.6% | 5,970 | +11.9% | 0.00% | – |
| Q2 2022 | $382,000 | -26.3% | 5,335 | +1.2% | 0.00% | – |
| Q1 2022 | $518,000 | -13.7% | 5,274 | -25.5% | 0.00% | – |
| Q4 2021 | $600,000 | -1.6% | 7,080 | -7.5% | 0.00% | – |
| Q3 2021 | $610,000 | -7.4% | 7,650 | +13.0% | 0.00% | – |
| Q2 2021 | $659,000 | +25.0% | 6,768 | +50.4% | 0.00% | – |
| Q1 2021 | $527,000 | +16.1% | 4,500 | +10.3% | 0.00% | – |
| Q4 2020 | $454,000 | +26.1% | 4,078 | +34.5% | 0.00% | – |
| Q3 2020 | $360,000 | +3.2% | 3,031 | -1.7% | 0.00% | – |
| Q2 2020 | $349,000 | +60.8% | 3,083 | -5.5% | 0.00% | – |
| Q1 2020 | $217,000 | -96.9% | 3,262 | -95.1% | 0.00% | -100.0% |
| Q2 2019 | $7,011,000 | +116.9% | 66,896 | +159.2% | 0.00% | +100.0% |
| Q1 2019 | $3,233,000 | +430.0% | 25,813 | +1083.0% | 0.00% | – |
| Q2 2018 | $610,000 | -95.7% | 2,182 | -98.2% | 0.00% | -100.0% |
| Q1 2018 | $14,320,000 | – | 122,612 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |